Unfortunately, as was evident in our patient, it is likely that PSMA expression in the tumor endothelium - rather than directly in the tumor cells - leads to poor retention of PSMA-targeted molecules, resulting in minimal radiation delivery and limited therapeutic efficacy in ICC and other solid tumors [4]. Here, FOLH1 is linked to intrahepatic cholangiocarcinoma.